Tuesday, May 05, 2026

What shapes the content of our dreams?

A new study of researchers at the IMT School for Advanced Studies Lucca reveals how personal traits and life experiences influence dream content


IMT School for Advanced Studies Lucca





Why do our dreams sometimes feel vivid and immersive, while at other times they seem fragmented or difficult to interpret? A new study conducted by researchers at the IMT School for Advanced Studies Lucca provides new insights into what determines the content of dreams, showing that both individual characteristics and shared life experiences play a key role in shaping what we dream.

The research, published in Communications Psychology, analyzed over 3,700 reports of dream and waking experiences collected from 287 participants aged 18 to 70. Over a two-week period, volunteers recorded their experiences daily, while researchers gathered detailed information about their sleep patterns, cognitive abilities, personality traits, and psychological characteristics.

Using advanced natural language processing (NLP) techniques, the team was able to quantitatively analyze the semantic structure of dreams. The findings reveal that dream content is not random or chaotic, but instead reflects a complex interplay between personal traits, such as tendency to mind-wander, interest in dreams, and sleep quality, and external events, including large-scale societal experiences like the COVID-19 pandemic.

When examining the words participants used to describe both their daily lives and their dreams, the research team observed how everyday life is transformed during sleep. Rather than simply replaying waking experiences, dreams appear to reinterpret them. Elements from daily routines, such as work environments, healthcare settings, or education, do not reappear as they are. Instead, they are reorganized into vivid, immersive scenarios, often blending together different contexts and shifting perspectives into unfamiliar landscapes. This suggests that dreams do not just reflect reality, but actively reshape it, integrating fragments of past experiences with imagined or anticipated ones to create novel, sometimes surreal, scenarios.

These transformations also vary across individuals. For example, individuals more prone to mind-wandering tended to report more fragmented and rapidly changing dream scenarios, while those who had a strong belief in the value, meaning, and significance of dreaming in general and of their dreams in particular, experienced perceptually richer and more immersive dream content. Analyses of data collected during the COVID-19 lockdown by researchers at Sapienza University of Rome, and compared with data gathered in the subsequent months and years by the IMT School team, showed that dreams during the lockdown were characterized by heightened emotional intensity and more frequent references to constraints and limitations, reflecting the broader social context. These effects gradually diminished over time, suggesting that dream content evolves in parallel with psychological adaptation to major life events.

“Our findings show that dreams are not just a reflection of past experiences, but a dynamic process shaped by who we are and what we live through,” explains Valentina Elce, researcher at the IMT School and lead author of the paper. “By combining large-scale data with computational methods, we were able to uncover patterns in dream content that were previously difficult to detect.”

The study also highlights the potential of artificial intelligence in dream research, demonstrating that NLP models can reliably capture the meaning and structure of dream reports with accuracy comparable to human independent evaluators. This opens new possibilities for studying consciousness, memory, and mental health in a scalable and reproducible way.

###

This work was supported by a grant from the BIAL Foundation (#091/2020) and by the TweakDreams ERC Starting Grant (#948891). The research was conducted at the IMT School for Advanced Studies Lucca, in collaboration with researchers from Sapienza University of Rome and the University of Camerino.

  

Dreaming while awake: Dream-like states are not confined to sleep





Institut du Cerveau (Paris Brain Institute)






By convention, wakefulness and sleep are regarded as physiologically distinct states. It is therefore tempting to assume that the images, sensations, and ideas that cross our minds while we are awake are fundamentally different in nature from those we experience while we sleep, and especially while we dream.

Yet this is far from obvious. Being awake is not synonymous with being attentive, fully aware of one's surroundings, or able to act and think rationally,” explains Delphine Oudiette, co-leader of the DreamTeam. “We now know that there is a continuum between wakefulness and sleep, with intermediate states such as mind-wandering or mind-blanking, during which certain regions of the brain may be asleep. What remained to be determined was whether the content of our thoughts also varies independently of our state of vigilance.”

To answer this question, the researchers chose to study sleep onset, the transitional stage between wakefulness and sleep.

Sleep onset allows us to capture, within a very short time span, fluctuations in our state of vigilance, from wakefulness to sleep, and to observe the mental experiences associated with them,” says Nicolas Decat, a PhD student at the Paris Brain Institute and first author of the study. “As we drift toward sleep, sensations, visions, and snippets of speech unfold—what are commonly called hypnagogic experiences. Tracing the evolution from ordinary thought to dream-like narrative can help us understand how a dream emerges.”

Nap experts to the rescue

To explore the transition between wakefulness and sleep, the team conducted a study with 92 participants who were accustomed to napping and trained to report the content of their thoughts upon interruption.

The researchers used an experimental setup inspired by Thomas Edison. According to legend, the inventor had a habit of falling asleep in his armchair while holding a heavy object, the fall of which would wake him at the threshold of sleep; he would then make use of the whirlwind of creative ideas that flooded his mind during this critical moment.

After each interruption of their nap—either by dropping a bottle held in the hand or by an alarm—participants were asked to describe their mental experience of the previous ten seconds, then rate it on four dimensions: bizarreness, fluidity, spontaneity, and perceived level of wakefulness. In parallel, their brain activity was continuously recorded with an EEG cap.

The researchers then let the data speak for themselves, applying a clustering algorithm that imposed no preconceived categories.

This data-driven approach was essential for us, because in research, there is no consensus on what hypnagogic experiences actually are. It was important not to bias this exploration with our own definitions or beliefs,” says Nicolas Decat.

A brain signature of dream-like states

The analysis revealed not the two mental states one might expect—dreaming and waking thought—but four. The first (C1) was characterized by fleeting recollections (“An image of my dad crossed my mind”); the second (C2), by a high level of connection to the surrounding environment (“I was listening to the street sounds”); the third (C3), by its bizarreness (“I saw images of small aliens”); and the last (C4), by a high level of voluntary control (“I was thinking about what I would do tomorrow”).

Each of these four mental states appeared across all three vigilance stages measured: wakefulness, sleep onset, and light sleep.

This is the major finding of our study. The mental states traditionally associated with dreaming can arise just as well when we are asleep as when we are awake. In other words, the content of our thoughts does not follow the boundaries between waking and sleep! One of our participants, while awake, reported seeing ants crawling on her body against a backdrop of crossword puzzles. Conversely, another participant mentally went through his schedule for the next day while he was fully asleep,” adds the researcher.

The team then went further, searching for neurophysiological markers specific to each mental state. By analyzing the complexity of the EEG signal, its spectral power, and the functional connectivity between brain regions, the researchers identified distinctive signatures.

They show that there is a specific brain signature for the “bizarre” C3 mental content—that is, the dream-like state. It is characterized by reduced long-range connectivity between the frontal and occipital regions of the brain.

This signature may well be the correlate of what we feel in such a state: lucid reasoning is overtaken by a whirlwind of vivid sensations characteristic of dreams,” suggests Nicolas Decat.

Mental activity and introspection

If dreaming is not specific to sleep, why do we have the impression that extravagant mental content occurs only in the depths of the night, when we are oblivious to the world around us?

This preconception probably stems from a memory bias. We mainly remember dreams that come with strong emotions or those to which we attach particular meaning. Yet it is just as common to dream that we are working!” notes Nicolas Decat. “Conversely, some people report that fanciful daytime thoughts—elusive, like fragments of a dream—sometimes surface during their everyday activities. Because these thoughts are seen as incongruous, they may well be more frequent than we imagine, but we tend to dismiss them."

Potential applications for sleep disorders

We are generally not very good at judging our own level of vigilance or describing the content of our thoughts. As a result, some people suffering from insomnia regularly complain of spending entire nights without sleeping, even though polysomnographic measurements taken in sleep clinics indicate otherwise.

This is what we call paradoxical insomnia: a mismatch between the patient's experience and clinical observations based on conventional sleep-stage criteria.

These criteria are probably inadequate. Our study proposes a new one—mental content— which may be better aligned with what these patients actually experience. Through this lens, some of them may spend an unusually long time in an alert state (C2), hyperconnected to the outside world, or, conversely, very little time in a dream-like state (C3), blurring the line between their waking and sleeping lives,” explains Delphine Oudiette. “Beyond giving patients' reports the weight they deserve, this approach paves the way to identifying objective markers of insomnia.”

 Dinner timing during pregnancy linked to epigenetic changes in the placenta


This is the first study to examine how meal timing during pregnancy may influence placental function through DNA methylation




Barcelona Institute for Global Health (ISGlobal)





It is not only what is eaten during pregnancy that matters, but also when it is eaten. This was the starting hypothesis of a chrononutrition study conducted by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the ”la Caixa” Foundation and published in Molecular Nutrition & Food Research. The researchers set out to take a first step in determining whether meal timing during pregnancy has any impact on placental function. The findings show that, among all daily meals, dinner is the only one whose timing is associated with changes in DNA methylation in the placenta.

DNA methylation involves the addition of small chemical markers (methyl groups) to DNA, which can switch genes on or off. It is part of epigenetics, a set of mechanisms that regulate gene activity without altering the DNA sequence. In the placenta, DNA methylation provides an indication of how gene activity is regulated in this organ, which is essential for fetal development.

“Later meal timing and lower meal frequency have been linked to factors such as gestational weight gain and gestational diabetes,” explains Joana Llauradó Pont, predoctoral researcher at ISGlobal and first author of the study. To explore its effects on placental epigenetics, the team conducted an epigenome-wide association study (EWAS) involving 389 women from the Barcelona Life Study (BiSC) cohort. Information on diet and chrononutrition habits was collected at week 20 of pregnancy, and placental tissue samples were obtained after delivery to analyse DNA methylation using “Illumina EPIC” technology.

“We focused on five key aspects,” adds Llauradó Pont, “the timing of the first and last meals, the duration of the overnight fast, the number of meals, and variability in meal timing.”

Dinner timing: a habit linked to epigenetic changes

The study identified changes in placental DNA methylation (hypo- or hypermethylation) mainly associated with the timing of the last meal of the day. Although this initial research did not establish an optimal dinner time, it did find that variations in this timing were linked to changes in the regulation of several genes, some involved in pregnancy-related biological processes. For instance, one plays a role in cholesterol metabolism, which is crucial for fetal development. Others are involved in the formation of blood vessels, the regulation of cell growth, and the DNA damage response. Signals were also observed in genes related to programmed cell death and the immune system.

“The timing of the last meal may act as a relevant time cue for the maternal body and, through epigenetic mechanisms, influence biological processes during pregnancy,” explains Camille Lassale, the study’s coordinator. “While a causal relationship cannot be established, these findings suggest that when food is consumed may modulate placental function and potentially have implications for fetal development.”

This study represents an initial step towards understanding how meal timing may influence placental function and opens the door to future research to clarify the specific role of eating schedules, why dinner stands out compared to other dietary habits, and which time windows may be associated with greater benefits during pregnancy.

Circadian rhythms and chrononutrition

Circadian rhythms are biological cycles of around 24 hours that regulate physiological and behavioural functions. They are controlled by internal “clocks”, such as the suprachiasmatic nucleus in the hypothalamus, which responds to light and darkness. There are also clocks in organs such as the liver and muscles, which are sensitive to signals like food intake. For this reason, meal timing influences the circadian system, and irregular eating patterns can affect health. Chrononutrition examines the relationship between diet, circadian rhythms, and health.

 

Survey finds many women still believe mammograms should start at age 50—experts say age 40



Nearly half of women misunderstand breast cancer screening guidelines, even as experts recommend yearly mammograms beginning at age 40



Ohio State University Wexner Medical Center





Key takeaways

  • 44% of women incorrectly believe mammograms should start at age 50.

  • The survey found widespread confusion about screening guidelines, which can delay detection.

  • CDC’s U.S. Cancer Statistics show breast cancer rates are rising among women younger than 45.

  • Experts urge women to talk with a health care provider about when to start mammograms based on age and risk.

COLUMBUS, Ohio – A new national survey reveals many women are unsure about when to start mammogram screening for breast cancer and believe they should start later than doctors recommend.

The survey, commissioned by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James), found that 44% of women incorrectly believe annual mammograms should start at age 50. Leading medical organizations recommend women at average risk for breast cancer begin yearly mammograms at age 40.

“Our biggest concern is ongoing confusion about screening guidelines,” said Alyssa Cubbison, DO, a breast radiologist at the OSUCCC – James. “For most women, breast cancer screening should begin with annual mammograms at age 40. Clear, accurate information helps women make informed decisions with their clinician and may lead to earlier detection.”

What major guidelines recommend

The confusion continues after the U.S. Preventive Services Task Force (USPSTF) updated its mammography recommendations in April 2024. The task force recommends women at average risk get a screening mammogram every other year starting at age 40. But many medical experts—including the Society of Breast Imaging and the American College of Radiology—continue to recommend annual screening starting at age 40 for average risk women, a guideline followed by the OSUCCC – James.

The survey also found that many women believe screening should start even earlier. More than half of women (51%) said mammograms should be done every year, and 41% believe screening should begin by age 35.

“Initiating screening mammography before the age of 40 is appropriate in only certain patients deemed to be higher risk based on factors such as family history and genetic mutations,” said Cubbison.

In April 2026, the American College of Physicians updated its guidance to recommend mammography for average‑risk women ages 50 to 74 occur every two years, citing individualized decision‑making. The OSUCCC – James follows radiology‑focused guidelines recommending yearly mammograms beginning at age 40. Under the Affordable Care Act, annual screening mammography starting at age 40 is covered under Medicare and most commercial insurance providers. Insurance coverage may vary; patients should check with their insurance provider about specific coverage.

Why starting mammograms at 40 matters

Experts say the confusion is especially concerning as breast cancer diagnoses in younger women rise. According to the Centers for Disease Control and Prevention’s U.S. Cancer Statistics, more than 27,000 U.S. women younger than 45 were diagnosed with breast cancer in 2022. CDC data also show the number of new cases in this age group increased an average of 0.7% per year from 2001 to 2022. Because younger women are not routinely screened, cancers in this group are more likely to be found at a later stage, when treatment can be more complex.

Why some women delay mammograms

Beyond confusion about screening guidelines, about half (53%) of the women surveyed cited some reported belief or reason for delaying or avoiding mammograms, including:

  • Cost (28%)
  • Discomfort (26%)
  • Believing they were too young (26 %)
  • Not having symptoms (25%)
  • Concerns about radiation exposure (21%)

Younger women: when to talk to a clinician

The survey also highlighted uncertainty among younger women. About one in four women ages 18 to 29 said they would wait until symptoms such as pain or a lump appear before seeing a doctor—an approach experts say can delay diagnosis and treatment.

Most women under 40 are not eligible for regular screening mammograms. But experts encourage younger women—especially those with a personal or family history of breast cancer—to talk with a clinician about their risk. Knowing whether you have dense breast tissue can also help. Dense breast tissue can raise risk and make cancers harder to detect on mammograms. The survey found that most women would take follow-up action if a mammogram showed dense breast tissue, including talking with a primary care doctor or gynecologist (60%) or requesting additional imaging such as ultrasound or MRI (54%).

“Sharing these findings is meant to correct misconceptions, clarify screening guidance and encourage women of all ages to talk with their health care providers about when to start mammograms and how to protect their breast health,” said Cubbison.

To learn more about breast cancer research and patient care at the OSUCCC – James, visit cancer.osu.edu/breastcancer. The OSUCCC – James also recently launched the Building Research Innovation and Care Delivery for Groups with Early-Onset Cancers (BRIDGE) initiative to support people diagnosed with cancer at a young age.

Survey methodology

This survey was conducted by SSRS on its Opinion Panel Omnibus platform. The SSRS Opinion Panel Omnibus is a national, twice-per-month, probability-based survey. Data collection was conducted from April 2-6, 2026, among a sample of 1,043 female respondents. The survey was conducted via web (n=1,014) and telephone (n=29) and administered in English. The margin of error for total respondents is +/-3.4 percentage points at the 95% confidence level. The Opinion Panel Omnibus data were weighted to represent the target population of U.S. female adults ages 18 or older.

###

 

A study in 1. 4 million women expands knowledge on endometriosis and its biological complexity




Institut de Recerca Sant Pau (Sant Pau Research Institute)
Dr. Dora Koller 

image: 

Dr. Dora Koller

view more 

Credit: IR Sant Pau






Endometriosis, a chronic inflammatory disease that affects approximately one in ten women of reproductive age—around 190 million worldwide—remains poorly understood from a biological perspective, which has historically hindered both its accurate diagnosis and the development of effective treatments. Now, an international study published in Nature Genetics provides new data to better understand the genetic basis and mechanisms involved in this condition.

The work, which analyzes genetic information from nearly 1.4 million women, including more than 100,000 cases of endometriosis, constitutes the largest study conducted to date on this disease. The research has been carried out by researchers in several institutions: Yale University (United States), Universitat de Barcelona, and the Sant Pau Research Institute (IR Sant Pau), among other centers in Europe and the United States. Its results have identified 80 regions of the genome associated with the risk of developing endometriosis, 37 of which had not been previously described, representing a significant advance in understanding its genetic architecture.

“When we study a disease, we need to understand its biological basis. If we do not know what is happening at the molecular level, it is very difficult to develop effective treatments or improve diagnosis,” explains Dr. Dora Koller, from the Perinatal and Women’s Health research group at IR Sant Pau and lead author of the study, who adds that basic research in endometriosis has arrived later than in other areas, which has limited understanding of the disease for years.

“This research leverages a multidisciplinary collaboration to improve endometriosis care. We are dedicated to translating our findings into actionable solutions for women worldwide,” said Dr. Renato Polimanti, senior author and Associate Professor of Psychiatry at the Yale School of Medicine.

This international study also highlights the participation of experts Bru CormandMarina Mitjans, and Selena Aranda, from the University of Barcelona Institute of Biomedicine (IBUB), the Sant Joan de Déu Research Institute (IRSJD), and the Mental Health (CIBERSAM) and Rare Diseases (CIBERER) areas of the CIBER.

An Integrative Approach to Understanding the Disease

Beyond the identification of new genetic regions, one of the main advances of the study is its ability to translate these findings into biological knowledge. The researchers did not limit themselves to identifying statistical associations typical of genome-wide studies but integrated genetic data with multiple layers of functional information to understand how these variants influence the expression of genes and proteins, and epigenetic processes. This approach has made it possible to go beyond the simple identification of genetic risk and to connect these associations with real biological processes, providing a more comprehensive and mechanistic view of the pathophysiology of endometriosis.

The results indicate that the disease does not respond to a single mechanism but to the interaction of multiple biological processes acting simultaneously and contributing both to its onset and progression. These include inflammation, altered immune response, tissue remodeling, cell proliferation and differentiation, and the formation of new blood vessels, processes that help explain the diversity of clinical manifestations observed among patients.

“What we see is that there is probably not a single cause, but many possible pathways that can contribute to the disease, and these likely vary between women,” notes Dr. Koller. “This finding reinforces the idea that endometriosis should be understood as a complex and systemic disease in which multiple interrelated biological mechanisms are involved,” she continues.

A Heterogeneous Disease With Poorly Defined Subtypes

This biological complexity is reflected in the wide clinical variability of the disease. Some women have hardly any symptoms, while others experience severe and disabling pain or infertility problems that significantly affect their quality of life. This diversity, both in clinical presentation and progression, highlights that endometriosis does not follow a single pattern.

In clinical practice, current classification is mainly based on surgical criteria or the location of lesions, which is limited, as it does not adequately explain differences in symptoms, progression, or response to treatment. This lack of more precise diagnostic tools also contributes to the fact that diagnosis of the disease is often delayed for an average of 7-10 years, even in women with evident symptoms.

“We need to move toward a more biologically based classification, similar to what has happened in cancer, where we now distinguish different subtypes with different behaviors and treatments,” notes Dr. Koller. She also acknowledges that this diagnostic delay is part of the experience of many women. As a patient with endometriosis, she notes that “in my case, it took 15 years to obtain a diagnosis, despite having clear and debilitating symptoms.”

This shift in approach would not only improve understanding of the disease but also allow diagnosis and treatment to be adapted to the specific characteristics of each patient, a key step toward more personalized medicine.

The Combined Role of Genetics and Environmental Factors

The study provides new insights into the role of genetics in endometriosis, although it confirms that genetic predisposition alone does not explain the development of the disease. Genetics only partly explain the development and progression of endometriosis, reinforcing the idea that the disease follows a complex model involving multiple factors.

In this regard, the results suggest that the interaction between genetics, environmental factors, and epigenetic mechanisms is not deterministic. Elements such as diet, exposure to certain chemical compounds, and many other factors may modulate its development and progression.

This approach helps explain why women with a similar genetic predisposition may present very different clinical trajectories, both in the onset of symptoms and in their severity or response to treatment. The observed variability does not depend solely on genetic load but on how it interacts with the environment over time.

Moreover, the analysis of polygenic risk combined with clinical information provides a particularly relevant result: in some cases, symptoms and comorbidities may play a more decisive role than genetics itself in identifying the disease. This finding challenges the idea that genetic risk is always the main indicator and reinforces the importance of a comprehensive clinical evaluation.

“In clinical practice, symptoms remain a key piece,” notes Dr. Koller. “Listening to patients and understanding their clinical history is essential when guiding diagnosis.” This perspective reinforces the need to more closely integrate genetic and clinical information in healthcare practice, with the aim of improving patient identification and advancing toward more precise and personalized care models.

New Opportunities for Diagnosis and Personalized Treatment

The study findings have direct implications in the clinical setting. Currently, the treatment of endometriosis is largely based on a trial-and-error approach, in which many patients try different therapies without obtaining satisfactory results, reflecting the lack of tools to predict individual response to treatments.

“The problem is not only that treatments do not work the same in all patients but that we do not have enough tools to anticipate which option will be most appropriate in each case,” explains Dr. Koller. “Genetics can help us better understand what is happening in each patient and guide therapeutic decisions more closely aligned with their biological profile.”

In this way, the integration of genetic, clinical, and molecular information opens the door to a more personalized approach, in which treatment can be adapted to the specific characteristics of each patient. This shift would not only improve the effectiveness of therapies but also reduce unnecessary exposure to ineffective treatments.

The study also identifies potential new therapeutic options through the repurposing of existing drugs, a strategy that allows accelerating the application of new treatments for endometriosis by building on medications with already known safety profiles. These include drugs used in oncology and others such as nortriptyline, which could have a dual effect by acting on both chronic pain and depression, two conditions frequently associated with the disease.

Clinical Impact, Diagnostic Challenges, and the Need for a Gender Perspective

Beyond its scientific contribution, this research is rooted in an urgent clinical and social reality: endometriosis remains a widely underdiagnosed disease that is too often normalized or dismissed. Diagnosis is frequently delayed by several years, a delay that not only limits access to appropriate treatment but also allows pain to become chronic and complications such as fertility problems or emotional distress to develop, among many others. It is precisely this reality that makes advancing our biological understanding of the disease so critical.

“Severe pain is never normal. If a woman cannot get out of bed during menstruation, it is a sign that something is wrong, and we must investigate it,” emphasizes Dr. Koller. Beyond the specific case of endometriosis, these results point to a broader challenge in biomedical research. “Diseases that exclusively affect women have historically been under-researched and have received fewer resources,” notes Dr. Koller. “Incorporating a gender perspective in research is not only a matter of equity but a necessity to advance knowledge and improve care.”